517 related articles for article (PubMed ID: 25461399)
1. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities.
Zhao H; Liu X; Zou H; Dai N; Yao L; Zhang X; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cell Adh Migr; 2016 May; 10(3):299-309. PubMed ID: 26743491
[TBL] [Abstract][Full Text] [Related]
3. The effect of P2X7R-mediated Ca
Ma Y; Zhao H; Chile C; Wang C; Zheng J; Song R; Zou H; Gu J; YanYuan ; Bian J; Liu Z
Exp Cell Res; 2019 Oct; 383(2):111555. PubMed ID: 31415763
[TBL] [Abstract][Full Text] [Related]
4. BAPTA-AM, an intracellular calcium chelator, inhibits RANKL-induced bone marrow macrophages differentiation through MEK/ERK, p38 MAPK and Akt, but not JNK pathways.
Zhou S; Yuan X; Liu Q; Zhang X; Pan X; Zang L; Xu L
Cytokine; 2010 Dec; 52(3):210-4. PubMed ID: 20667748
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities.
Shyu JF; Shih C; Tseng CY; Lin CH; Sun DT; Liu HT; Tsung HC; Chen TH; Lu RB
Bone; 2007 May; 40(5):1329-42. PubMed ID: 17321230
[TBL] [Abstract][Full Text] [Related]
6. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.
Hotokezaka H; Sakai E; Kanaoka K; Saito K; Matsuo K; Kitaura H; Yoshida N; Nakayama K
J Biol Chem; 2002 Dec; 277(49):47366-72. PubMed ID: 12237315
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effects of areca nut extracts on prostaglandin E2 production by human polymorphonuclear leukocytes.
Lai YL; Wu CY; Lee YY; Chang HW; Liu TY; Hung SL
J Periodontol; 2010 May; 81(5):758-66. PubMed ID: 20429655
[TBL] [Abstract][Full Text] [Related]
9. Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathway.
Tsubaki M; Kato C; Isono A; Kaneko J; Isozaki M; Satou T; Itoh T; Kidera Y; Tanimori Y; Yanae M; Nishida S
J Cell Biochem; 2010 Dec; 111(6):1661-72. PubMed ID: 21053363
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways.
Tiedemann K; Hussein O; Sadvakassova G; Guo Y; Siegel PM; Komarova SV
J Biol Chem; 2009 Nov; 284(48):33662-70. PubMed ID: 19801662
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
[TBL] [Abstract][Full Text] [Related]
13. The effect of P2X7R- mediated Ca
Ma Y; Ran D; Zhao H; Shi X; Song R; Zou H; Liu Z
Life Sci; 2022 Mar; 293():120337. PubMed ID: 35074408
[TBL] [Abstract][Full Text] [Related]
14. CaMKII(δ) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway.
Lu DZ; Dong W; Feng XJ; Chen H; Liu JJ; Wang H; Zang LY; Qi MC
Mol Cell Endocrinol; 2020 May; 508():110791. PubMed ID: 32173349
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation.
Fu Y; Gu J; Wang Y; Yuan Y; Liu X; Bian J; Liu ZP
J Vet Sci; 2015; 16(2):151-6. PubMed ID: 25549213
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling.
Ma Y; Shi X; Zhao H; Song R; Zou H; Zhu J; Liu Z
Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35266010
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the extracellular signal-regulated protein kinase (ERK) pathway in the induction of apoptosis by cadmium chloride in CCRF-CEM cells.
Iryo Y; Matsuoka M; Wispriyono B; Sugiura T; Igisu H
Biochem Pharmacol; 2000 Dec; 60(12):1875-82. PubMed ID: 11108803
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways.
Tsubaki M; Kato C; Manno M; Ogaki M; Satou T; Itoh T; Kusunoki T; Tanimori Y; Fujiwara K; Matsuoka H; Nishida S
Mol Cell Biochem; 2007 Oct; 304(1-2):53-60. PubMed ID: 17549607
[TBL] [Abstract][Full Text] [Related]
19. Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling.
Li S; Yang B; Teguh D; Zhou L; Xu J; Rong L
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735865
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative.
Itoh N; Kasai H; Ariyoshi W; Harada E; Yokota M; Nishihara T
J Periodontal Res; 2006 Aug; 41(4):273-9. PubMed ID: 16827720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
